课题基金 / 基金详情

Transformative Bioglass Coatings for Surgical Applications

Transformative Bioglass Coatings for Surgical Applications
用于外科应用的变革性生物玻璃涂层
批准号:
462508-2014
负责人:
Towler, Mark
金额:
$3.59万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Towler, Mark的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to design surgical coats that retard bacterial infection and promote formation of dense bone in patients with low bone mass or compromised healing, this project has three interrelated objectives: 1) Apply regression models to formulate borate glasses substituted with ions of therapeutic ability that have thermal expansion comparable to Ti6Al4V implants. 2) Identify processing parameters based on viscous flow to enamel the glasses onto implants. 3) Evaluate their surgical applicability through mechanical, biological and clinical techniques. The team will test three hypotheses: 1) A statistical model can identify degradable borate glasses. 2) Glasses can be glazed onto Ti6Al4V substrates. 3) Coats degrade in vivo, inhibiting bacterial proliferation and stimulating bone formation through ion release, with or without the incorporation of bone morphogenetic proteins, which promote bone formation, thus minimizing the need for revision. The research will synergize results from engineering and medicine to design glasses with comparable thermal expansion to metal. Surgical glass coats are not clinically available because silica glasses crack during glazing. The team has developed silica glasses containing active ionic species that minimize bacterial proliferation and stimulate dense bone formation. The incorporation of the active ions from the previous research, into a borate, rather than silicate, glass, could eliminate cracking caused by mismatched thermal expansion, offering coating applications. Borate-based coatings may reduce common causes of revision: aseptic loosening, sepsis and cases where a patients healing process is compromised. The commercialization of this technology will decrease the need for revision surgeries, which represented 10.1% of the reported 17,303 hip replacement surgeries performed in 2010-11. At double the primary surgery cost, the demand for revision arthroplasty is placing considerable strain on the Canadian healthcare system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure-property relationships in ionically substituted bioactive glasses.
  • 批准号:
    RGPIN-2019-04634
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.84万
  • 财政年份:
    2022
  • 负责人:
    Towler, Mark
  • 依托单位:
Structure-property relationships in ionically substituted bioactive glasses.
  • 批准号:
    RGPIN-2019-04634
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.84万
  • 财政年份:
    2021
  • 负责人:
    Towler, Mark
  • 依托单位:
Structure-property relationships in ionically substituted bioactive glasses.
  • 批准号:
    RGPIN-2019-04634
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.84万
  • 财政年份:
    2020
  • 负责人:
    Towler, Mark
  • 依托单位:
Structure-property relationships in ionically substituted bioactive glasses.
  • 批准号:
    RGPIN-2019-04634
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.84万
  • 财政年份:
    2019
  • 负责人:
    Towler, Mark
  • 依托单位:
国内基金
海外基金
Bioglass@CNF中生物活性玻璃纳米粒子的成核生长机理及生物矿化行为研究
  • 批准号:
    51102008
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2011
  • 负责人:
    贾晓龙
  • 依托单位: